-
PurposeMammalian expression of 3xFLAG tagged, nuclear localized TPP1, N-terminal.
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 53585 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1
-
Backbone manufacturerInvitrogen/LIfe Technologies
- Backbone size w/o insert (bp) 5500
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameTPP1
-
Alt nameACD
-
Alt namePTOP
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1632
-
MutationSilent mutation to eliminate PacI site
-
GenBank ID
-
Entrez GeneACD (a.k.a. PIP1, PTOP, TINT1, TPP1)
- Promoter CMV
-
Tags
/ Fusion Proteins
- 3xFLAG (N terminal on backbone)
- NLS (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site AscI (not destroyed)
- 3′ cloning site PacI (not destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer BGH reverse (Common Sequencing Primers)
Resource Information
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCDNA-3xFLAG-NLS-TPP1 was a gift from Steven Artandi (Addgene plasmid # 53585 ; http://n2t.net/addgene:53585 ; RRID:Addgene_53585) -
For your References section:
TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends. Zhong FL, Batista LF, Freund A, Pech MF, Venteicher AS, Artandi SE. Cell. 2012 Aug 3;150(3):481-94. doi: 10.1016/j.cell.2012.07.012. 10.1016/j.cell.2012.07.012 PubMed 22863003